Related Experiment Video
Updated: Aug 29, 2026
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Cell protection, resistance and invasiveness of two malignant mesotheliomas as assessed by 10K-microarray
Steve Mohr1, Gérard Keith, Françoise Galateau-Salle
1Département Polluants et Santé, Institut National de Recherche et de Sécurité, 30 Rue Lionnois, 54000 Vandoeuvre-les-Nancy, France.
Abstract:
Malignant pleural mesothelioma (MPM) is an aggressive serosal tumor, strongly associated with former exposure to asbestos fibers and for which there is currently no effective treatment available. In human, MPM is characterized by a high local invasiveness, poor prognosis and therapeutic outcomes. In order to assess molecular changes that specify this phenotype, we performed a global gene expression profiling of human MPM. Using a 10,000-element microarray, we analyzed mRNA relative gene expression levels by comparing a mesothelioma cell line to either a pleural cell line or tumor specimens. To analyze these gene expression data, we used various bioinformatics softwares. Hierarchical clustering methods were used to group genes and samples with similar expression in an unsupervised mode. Genes of known function were further sorted by enzyme, function and pathway clusters using a supervised software (IncyteGenomics). Taken together, these data defined a molecular fingerprint of human MPM with more than 700 up- or down-regulated genes related to several traits of the malignant phenotype, specially associated with MPM invasiveness, protection and resistance to anticancer defenses. This portrait is meaningful in disease classification and management, and relevant in finding new specific markers of MPM. These molecular markers should improve the accuracy of mesothelioma diagnosis, prognosis and therapy.
Insights
Researchers identified over 700 gene expression changes in malignant pleural mesothelioma (MPM), an aggressive asbestos-related cancer. These molecular markers could improve MPM diagnosis, prognosis, and treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Malignant pleural mesothelioma (MPM) is an aggressive cancer linked to asbestos exposure.
- Current treatments for MPM are ineffective, highlighting the need for better diagnostic and therapeutic approaches.
Purpose of the Study:
- To identify molecular changes associated with the malignant phenotype of human MPM.
- To establish a molecular fingerprint of MPM for improved disease classification and management.
Main Methods:
- Global gene expression profiling using a 10,000-element microarray.
- Analysis of mRNA levels comparing MPM cell lines to pleural cells and tumor specimens.
- Bioinformatic analysis including hierarchical clustering and supervised gene sorting.
Main Results:
- Over 700 genes were found to be significantly up- or down-regulated in MPM.
- Identified genes are related to MPM invasiveness, immune evasion, and resistance to therapy.
- A distinct molecular fingerprint for human MPM was established.
Conclusions:
- The identified molecular fingerprint provides insights into MPM pathogenesis.
- These molecular markers hold potential for improving mesothelioma diagnosis, prognosis, and therapeutic strategies.
- Further research into these markers could lead to targeted therapies for MPM.
